Chiasma Inc.

CHIASMA

Pharmaceutical [ and veterinary ] preparations for the treatment and prophylaxis of [ infections, physiological disorders, ] endocrine disorders, [ respiratory diseases, ] gastro-intestinal disorders, circulatory disorders, neurological disorders, [ dermatological conditions, immune-deficiencies, organ damage, ] and cell proliferation [ and blood disorders ];

CHIASMA

scientific and technological services, namely, scientific research in the field of infections, physiological disorders, hormonal disorders, respiratory diseases, gastro-intestinal disorders, circulatory disorders, dermatological conditions, immuno-deficiencies, organ damage, cell proliferation, neurological disorders, genito-urinary disorders, musculoskeletal disorders and blood disorders; providing information and consultancy in the field of scientific research in the fields of infections, physiological disorders, hormonal disorders, respiratory diseases, gastro-intestinal disorders, circulatory disorders, dermatological conditions, immuno-deficiencies, organ damage, cell proliferation, neurological disorders, genito-urinary disorders, musculoskeletal disorders and blood disorders;

FERRICAP

Pharmaceutical preparations and substances; veterinary preparations and substances; preparations and formulations containing iron for pharmaceutical and veterinary use; iron compounds and formulations for pharmaceutical and veterinary purposes;

FERRILIN

pharmaceutical preparations and substances; veterinary preparations and substances; preparations and formulations containing iron for pharmaceutical and veterinary use; iron compounds and formulations for pharmaceutical and veterinary purposes;

KINE-8

pharmaceuticals; pharmaceuticals for regulating appetite and satiety; pharmaceuticals for treating obesity and metabolic disorders, and pharmaceuticals for reducing liver size prior to surgery;KINE-EIGHT;

KINEIGHT

pharmaceuticals; pharmaceuticals for regulating appetite and satiety; pharmaceuticals for treating obesity and metabolic disorders, and pharmaceuticals for reducing liver size prior to surgery;KINE EIGHT;

TPE

pharmaceutical and veterinary preparations, namely, oral delivery enhancement agents to facilitate improved absorbtion of a variety of pharmaceuticals and veterinary preparations;